市場調査レポート
商品コード
1182301
ラボ用ロボットの世界市場予測(~2028年):製品・用途・地域別の分析Laboratory Robotics Market Forecasts to 2028 - Global Analysis By Product, Application and Geography |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ラボ用ロボットの世界市場予測(~2028年):製品・用途・地域別の分析 |
出版日: 2022年12月12日
発行: Stratistics Market Research Consulting
ページ情報: 英文 175+ Pages
納期: 2~3営業日
|
世界のラボ用ロボットの市場規模は、2022年に2億1,962万米ドルを占め、予測期間中に8.72%のCAGRで成長し、2028年には3億6,268万米ドルに達すると予測されています。
現場労働者の安全を守る必要性の高まりや、研究所における厳しい規制の実施により、重要プロセスの用途にロボット技術を採用し始めています。
当レポートでは、世界のラボ用ロボット市場について調査分析し、市場動向、セグメント別、地域別の市場分析や、主要企業のプロファイルなどを提供しています。
According to Stratistics MRC, the Global Laboratory Robotics Market is accounted for $219.62 million in 2022 and is expected to reach $362.68 million by 2028 growing at a CAGR of 8.72% during the forecast period. The use of robotics technology to conduct scientific experiments and research in a secure environment without the intervention of human hands is the general concept of laboratory robotics. Companies are commencing to adopt robotic technologies for essential process applications due to the increasing need to safeguard the safety of manual workers and the implementation of strict regulatory norms in laboratories.
Market Dynamics:
Driver:
Safety of both humans and property to drive the market
Chemicals and other substances that are toxic when they come into direct contact with the human body are used in laboratory experiments. To prevent these compounds, a number of precautionary measures are being used in the labs. There have been various cases where experimental trials have harmed researchers. In some risky situations, they can even result in death.
Restraint:
Slow adoption of automation among small and medium-sized laboratories
Budget restrictions prevent many small and medium-sized laboratories from adopting automation. Another significant barrier to adoption of laboratory informatics solutions is their high maintenance and service expenses. Industry analysts claim that the maintenance costs of IT solutions exceed the cost of the product. In addition, a lack of evidence about the cost-effectiveness of automation solutions for small and medium-sized laboratories, as well as low risk-taking capacity, are limiting the growth of the lab robotics market.
Opportunity:
Improving healthcare infrastructure across emerging countries
During the projection period, manufacturers and distributors of lab automation products are estimated to significantly benefit from emerging markets. Increased sales of lab automation products are being driven by an increase in the demand for clinical diagnostic processes. Furthermore, major product manufacturers are expanding their distribution networks and manufacturing capacities to increase their penetration in emerging markets.
Threat:
Limited feasibility with technology integration in analytical labs
The obstacles in transferring data and communication standards between automated instruments from two distinct manufacturers and the evolving nature of laboratory work require automated systems with higher flexibility and interface capabilities. A significant difficulty for providers of lab automation solutions is producing products that are compatible with other systems in a lab.
COVID-19 Impact:
The COVID-19 pandemic has increased pressure on pharma and clinical labs while advancing drug discovery and research activities. Shortening TAT has acquired increased importance and is trending in robots, microplate readers, and automated liquid handlers. Moreover, the pandemic has caused hospitals and health systems to endure declining revenues, margins, and investments in automation and technology, resulting in long-term market effects for lab automation.
The drug discovery segment is expected to be the largest during the forecast period
Due to the substantial involvement of government and private agencies in the development of novel drugs in the pharmaceutical industry, the drug discovery segment of the worldwide laboratory robotics market is anticipated to be the largest. Furthermore, because of their extensive use in the industry to accurately perform a variety of tasks, this is shaping the market for laboratory robotics. Additionally, it is expected that industry growth would be prompted by the increasing pressure on healthcare providers to reduce healthcare costs.
The biotechnology & pharmaceutical industries segment is expected to have the highest CAGR during the forecast period
Owing to the high prevalence of pharmaceutical companies and the increased use of robotics and laboratory automation, the biotechnology & pharmaceutical industries are expected to grow. Further boosting the market growth in the laboratory robots has expanded from assisting product manufacturing & quality control in laboratory applications to R&D within pharmaceutical firms.
Region with largest share:
Due to market leaders' investments and rising technological breakthroughs, the market for laboratory robotics in North America is growing at a robust pace in the globe. Additionally, the market in this region is witnessing business partnerships and collaborations to achieve a technological advancement in the field of robotics, which is also strengthening the focus on technology.
Region with highest CAGR:
Increased demand for laboratory automation systems, an increase in the number of pharmaceutical companies, and increased awareness of advanced laboratory automation systems contributes to the market's expansion in the Asia Pacific region. Additionally, factors such as the development of the R&D sector, the growth of hospitals with cutting-edge medical equipment, the implementation of healthcare reforms, and improvements in the healthcare infrastructure all assist in the market's rise.
Key players in the market
Some of the key players in Laboratory Robotics market include Tecan Group, Beckman Coulter Inc, Peak Analysis & Automation (PAA), Biomerieux SA, Abbott Laboratories, Thermo Fisher Scientific, PerkinElmer Inc., Hudson Robotics Inc., Hamilton Company, Universal Robotics and Anton Paar GmbH
Key Developments:
In May 2018, Thermofisher Scientific, a leading company in the laboratory robotics market, announced that it is collaborating with Astex Pharmaceuticals, a pioneer in innovative drug discovery and development. Astex Pharmaceuticals picked Thermo Fisher Scientific Glacios Cryo-Transmission Electron Microscope (Cryo-TEM) to help them in drug discovery and development program.
Products Covered:
Applications Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances